Cargando…
CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition
Malignant pleural mesothelioma is an aggressive cancer, heterogeneous in its presentation and behaviour. Despite an increasing knowledge about molecular markers and their diagnostic and prognostic value, they are not used as much as they might be for treatment allocation. It has been recently report...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281343/ https://www.ncbi.nlm.nih.gov/pubmed/34277422 http://dx.doi.org/10.3389/fonc.2021.678447 |